Molecular mechanisms of SCLC initiation and detection in mice and humans
Molecular mechanisms of SCLC initiation and detection in mice and humans
批准号:
10245149
负责人:
MARK A KRASNOW
金额:
$56.75万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-09-19 至 2023-08-31
关键词:
Cell Culture TechniquesCellsDataDetectionDiagnosisDiseaseEarly DiagnosisEarly treatmentEnvironmentEpithelialEpithelial CellsEventGene Expression ProfileGeneticGenetic EngineeringGenetically Engineered MouseGenomic approachGenomicsGoalsHumanHuman GeneticsImmune mediated destructionIndividualInjuryLife ExpectancyLimited StageLungMalignant NeoplasmsMethodsMinorMolecularMusMutateMutationNeoplasm MetastasisNeuroendocrine CellNeuroendocrine TumorsNeuropeptidesNeurosecretory SystemsNon-Invasive Cancer DetectionOncogenicParaneoplastic SyndromesPatientsPeptidesPhaseProcessProliferatingResectedResolutionSignal TransductionSpecimenSurvival RateTP53 geneTimeTumor Suppressor ProteinsWidespread Diseasebasebronchial epitheliumcancer stem cellearly detection biomarkerseffective therapyinjuredinjured airwayinjury and repairinsightlung small cell carcinomamouse geneticsmouse modelneoplastic cellneuroendocrine cancerneurosensorynew therapeutic targetnovelnovel strategiespremalignantprogramsscreeningsingle-cell RNA sequencingstem cell populationstem cell proliferationstem cellstumortumor behaviortumor initiation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Small cell lung carcinoma (SCLC) is one of the deadliest cancers, a “recalcitrant” cancer for which there
is no effective treatment except when the disease is diagnosed early. However, only a small fraction of patients
are diagnosed early in disease. The greatest challenge to early diagnosis is that SCLC tumor cells typically
acquire an exceptional mutation burden and metastasize early, so for most patients disease has spread
beyond the lung at the time of diagnosis. The key to developing effective early diagnosis and treatment
methods is to elucidate the earliest molecular and cellular events of tumor initiation to uncover ones that can
be detected by screening during the premalignant phase of the disease. The goal of this proposal is to define
the early, premalignant molecular and cellular events of SCLC, so that they can be detected early and
destroyed before they become a deadly, untreatable disease.
SCLC is a neuroendocrine cancer. The prominent cell of origin is pulmonary neuroendocrine (NE) cells,
neurosensory and neurosecretory epithelial cells that sense and respond to the environment in the lung.
Recently, a minor subpopulation of NE cells was found to have stem cell activity, proliferating, dispersing, and
replenishing the surrounding bronchial epithelium following severe airway injury. Loss of tumor suppressors Rb
and p53 constitutively activates the stem cell program within days of loss of the tumor suppressors, even in the
absence of injury. In this proposal, a combination of genetics, cell culture, and single-cell genomics is used to
systematically interrogate these stem cells at cellular resolution, both in healthy lungs and in the early,
premalignant stage of SCLC. The goal is to define the molecular events immediately following loss of Rb and
p53 that constitutively activate the stem cell program and initiate their transformation into cancer stem cells that
spread, mutate, and escape immune destruction, and to identify the signals they secrete that might allow the
tumors to be detected before they become deadly.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular mechanisms of SCLC initiation and detection in mice and humans
-
批准号:10469595
-
项目类别:
-
资助金额:$53.31万
-
财政年份:2018
-
负责人:MARK A KRASNOW
-
依托单位:
Molecular mechanisms of SCLC initiation and detection in mice and humans
-
批准号:9788319
-
项目类别:
-
资助金额:$57.31万
-
财政年份:2018
-
负责人:MARK A KRASNOW
-
依托单位:
Interrogation of individual cells to identify progenitor cells and their niches
-
批准号:8114057
-
项目类别:
-
资助金额:$101.61万
-
财政年份:2009
-
负责人:MARK A KRASNOW
-
依托单位:
Interrogation of individual cells to identify progenitor cells and their niches
-
批准号:7833775
-
项目类别:
-
资助金额:$102.18万
-
财政年份:2009
-
负责人:MARK A KRASNOW
-
依托单位:
Interrogation of individual cells to identify progenitor cells and their niches
-
批准号:8264175
-
项目类别:
-
资助金额:$101.85万
-
财政年份:2009
-
负责人:MARK A KRASNOW
-
依托单位:
Interrogation of individual cells to identify progenitor cells and their niches
-
批准号:7939774
-
项目类别:
-
资助金额:$100.35万
-
财政年份:2009
-
负责人:MARK A KRASNOW
-
依托单位:
Interrogation of individual cells to identify progenitor cells and their niches
-
批准号:8465258
-
项目类别:
-
资助金额:$97.19万
-
财政年份:2009
-
负责人:MARK A KRASNOW
-
依托单位:
Interrogation of individual cells to identify lung progenitors and their niches
-
批准号:7678335
-
项目类别:
-
资助金额:$3.25万
-
财政年份:2008
-
负责人:MARK A KRASNOW
-
依托单位:
Stanford Career Development Program in the Genetics & Genomics of Lun Diseases
-
批准号:7325465
-
项目类别:
-
资助金额:$39.96万
-
财政年份:2007
-
负责人:MARK A KRASNOW
-
依托单位:
Stanford Career Development Program in the Genetics & Genomics of Lun Diseases
-
批准号:7664318
-
项目类别:
-
资助金额:$39.96万
-
财政年份:2007
-
负责人:MARK A KRASNOW
-
依托单位:
Stanford Career Development Program in the Genetics & Genomics of Lun Diseases
-
批准号:7500811
-
项目类别:
-
资助金额:$39.96万
-
财政年份:2007
-
负责人:MARK A KRASNOW
-
依托单位:
Stanford Career Development Program in the Genetics & Genomics of Lun Diseases
-
批准号:7903437
-
项目类别:
-
资助金额:$39.96万
-
财政年份:2007
-
负责人:MARK A KRASNOW
-
依托单位:
Stanford Career Development Program in the Genetics & Genomics of Lun Diseases
-
批准号:8121635
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2007
-
负责人:MARK A KRASNOW
-
依托单位:
The Gene Expression Program of Mouse Lung Development
-
批准号:6730464
-
项目类别:
-
资助金额:$34.46万
-
财政年份:2003
-
负责人:MARK A KRASNOW
-
依托单位:
The Gene Expression Program of Mouse Lung Development
-
批准号:6942666
-
项目类别:
-
资助金额:$34.69万
-
财政年份:2003
-
负责人:MARK A KRASNOW
-
依托单位:
The Gene Expression Program of Mouse Lung Development
-
批准号:7118229
-
项目类别:
-
资助金额:$33.99万
-
财政年份:2003
-
负责人:MARK A KRASNOW
-
依托单位:
The Gene Expression Program of Mouse Lung Development
-
批准号:6803506
-
项目类别:
-
资助金额:$34.58万
-
财政年份:2003
-
负责人:MARK A KRASNOW
-
依托单位:
CELLULAR COMMUNICATION IN MORPHOGENESIS
-
批准号:2185165
-
项目类别:
-
资助金额:$12.28万
-
财政年份:1991
-
负责人:MARK A KRASNOW
-
依托单位:
CELLULAR COMMUNICATION IN MORPHOGENESIS
-
批准号:6519500
-
项目类别:
-
资助金额:$17.63万
-
财政年份:1991
-
负责人:MARK A KRASNOW
-
依托单位:
CELLULAR COMMUNICATION IN MORPHOGENESIS
-
批准号:2749904
-
项目类别:
-
资助金额:$19.36万
-
财政年份:1991
-
负责人:MARK A KRASNOW
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: